Filtered By:
Specialty: Allergy & Immunology
Infectious Disease: Herpes
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
Predictors of herpes zoster vaccination among Australian adults aged 65 and over
CONCLUSION(S): Further research is required to understand the barriers to HZ vaccine uptake. Increasing the funding eligibility for those who are at risk of complications from shingles, or lowering the age of eligibility, may increase vaccine coverage.PMID:36336528 | DOI:10.1016/j.vaccine.2022.10.064
Source: Vaccine - November 6, 2022 Category: Allergy & Immunology Authors: Thomas Ricks Mallory J Trent C Raina MacIntyre Source Type: research
Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
CONCLUSIONS: HZ/su reduces the risk of HZ-associated complications in older adults (NCT01165177; NCT01165229).
PMID: 29463421 [PubMed - as supplied by publisher]
Source: Vaccine - February 17, 2018 Category: Allergy & Immunology Authors: Kovac M, Lal H, Cunningham AL, Levin MJ, Johnson RW, Campora L, Volpi A, Heineman TC, ZOE-50/70 Study Group Tags: Vaccine Source Type: research
